These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 15654688)

  • 21. Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation.
    Monroe AT; Hinerman RW; Amdur RJ; Morris CG; Mendenhall WM
    Head Neck; 2003 Jul; 25(7):529-34. PubMed ID: 12808655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multidisciplinary treatment of olfactory neuroblastoma: Patterns of failure and management of recurrence.
    Petruzzelli GJ; Howell JB; Pederson A; Origitano TC; Byrne RW; Munoz L; Emami B; Clark JI
    Am J Otolaryngol; 2015; 36(4):547-53. PubMed ID: 25749259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Esthesioneuroblastoma in childhood and adolescence. Better prognosis with multimodal treatment?
    Eich HT; Müller RP; Micke O; Kocher M; Berthold F; Hero B
    Strahlenther Onkol; 2005 Jun; 181(6):378-84. PubMed ID: 15925980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transnasal, transfacial, anterior skull base resection of olfactory neuroblastoma.
    Nabili V; Kelly DF; Fatemi N; St John M; Calcaterra TC; Abemayor E
    Am J Otolaryngol; 2011; 32(4):279-85. PubMed ID: 20728963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Olfactory neuroblastoma: a single-center experience.
    König M; Osnes T; Jebsen P; Evensen JF; Meling TR
    Neurosurg Rev; 2018 Jan; 41(1):323-331. PubMed ID: 28540633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
    Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Olfactory neuroblastoma: the long-term outcome and late toxicity of multimodal therapy including radiotherapy based on treatment planning using computed tomography.
    Mori T; Onimaru R; Onodera S; Tsuchiya K; Yasuda K; Hatakeyama H; Kobayashi H; Terasaka S; Homma A; Shirato H
    Radiat Oncol; 2015 Apr; 10():88. PubMed ID: 25888953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endoscopic resection of esthesioneuroblastoma.
    Casiano RR; Numa WA; Falquez AM
    Am J Rhinol; 2001; 15(4):271-9. PubMed ID: 11554661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Esthesioneuroblastoma: continued follow-up of a single institution's experience.
    Loy AH; Reibel JF; Read PW; Thomas CY; Newman SA; Jane JA; Levine PA
    Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):134-8. PubMed ID: 16490869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
    Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
    Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Olfactory neuroblastoma: results of combined therapy.
    Tandon DA; Bahadur S; Mohanti BK; Rath GK
    Indian J Cancer; 1994 Jun; 31(2):124-9. PubMed ID: 7927445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of Bcl-2 in olfactory neuroblastoma and its association with chemotherapy and survival.
    Kim JW; Kong IG; Lee CH; Kim DY; Rhee CS; Min YG; Kim CW; Chung JH
    Otolaryngol Head Neck Surg; 2008 Nov; 139(5):708-12. PubMed ID: 18984268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Olfactory neuroblastoma: a case report and review of the literature.
    Ghaffar S; Salahuddin I
    Ear Nose Throat J; 2005 Mar; 84(3):150-2. PubMed ID: 15871582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors.
    Jethanamest D; Morris LG; Sikora AG; Kutler DI
    Arch Otolaryngol Head Neck Surg; 2007 Mar; 133(3):276-80. PubMed ID: 17372086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Esthesioneuroblastoma: reflections of a 21-year experience.
    Levine PA; Gallagher R; Cantrell RW
    Laryngoscope; 1999 Oct; 109(10):1539-43. PubMed ID: 10522919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Esthesioneuroblastoma: endoscopic nasal and anterior craniotomy resection.
    Devaiah AK; Larsen C; Tawfik O; O'Boynick P; Hoover LA
    Laryngoscope; 2003 Dec; 113(12):2086-90. PubMed ID: 14660907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Olfactory neuroblastoma: past, present, and future?
    Lund VJ; Howard D; Wei W; Spittle M
    Laryngoscope; 2003 Mar; 113(3):502-7. PubMed ID: 12616204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Esthesioneuroblastoma in children and adolescent: experience on 11 cases with literature review.
    El Kababri M; Habrand JL; Valteau-Couanet D; Gaspar N; Dufour C; Oberlin O
    J Pediatr Hematol Oncol; 2014 Mar; 36(2):91-5. PubMed ID: 24390450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient characteristics of olfactory neuroblastoma: experience from a tertiary cancer centre 2000-2016 covering Eastern Denmark.
    Gram SB; Grønhøj C; Mann H; Jakobsen KK; Kiss K; Bilde A; von Buchwald C
    APMIS; 2018 Aug; 126(8):663-666. PubMed ID: 30168622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas M D Anderson Cancer Center experience.
    Kassouf W; Spiess PE; Siefker-Radtke A; Swanson D; Grossman HB; Kamat AM; Munsell MF; Guo CC; Czerniak BA; Dinney CP
    Cancer; 2007 Aug; 110(4):764-9. PubMed ID: 17614317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.